Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications

Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications

Abstract Background Idiopathic Pulmonary Fibrosis is a chronic, progressive interstitial lung disease for which there is no cure. However, lung function decline, hospitalizations, and mortality may be reduced with the use of the antifibrotic medications, nintedanib and pirfenidone. Historical outcom...

Full description

Bibliographic Details
Main Authors: Bryan T. Kelly, Viengneesee Thao, Timothy M. Dempsey, Lindsey R. Sangaralingham, Stephanie R. Payne, Taylor T. Teague, Teng Moua, Nilay D. Shah, Andrew H. Limper
Format: Article
Language:English
Published: BMC 2021-07-01
Series:BMC Pulmonary Medicine
Subjects:
Idiopathic pulmonary fibrosis
Antifibrotics
Hospitalization
Critical care
Mechanical ventilation
Online Access:https://doi.org/10.1186/s12890-021-01607-2

Internet

https://doi.org/10.1186/s12890-021-01607-2

Similar Items